Search

Your search keyword '"Gallia, Francesca"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Gallia, Francesca" Remove constraint Author: "Gallia, Francesca"
40 results on '"Gallia, Francesca"'

Search Results

2. Prospective open- label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.

4. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

7. The circular RNA landscape in multiple sclerosis: Disease-specific associated variants and exon methylation shape circular RNA expression profile

10. Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP

11. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

12. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis

13. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP

15. Chronic inflammatory demyelinating polyradiculoneuropathy: Can we make a diagnosis in patients not fulfilling electrodiagnostic criteria?

19. Chronic motor axonal neuropathy

20. High-dose immunoglobulin pulse therapy and risk of Covid19 infection

21. Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy

24. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

27. Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis

31. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP

32. Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation

33. Frequency and Time to Relapse after Discontinuing 6-month Therapy with Intravenous Immunoglobulin or Methylprednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (P7.002)

34. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

38. A Randomized, Double Blind, Controlled Trial of Intravenous Immunoglobulins Versus Intravenous Methylprednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (IMC Study)

39. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis

40. High-dose immunoglobulin pulse therapy and risk of Covid19 infection

Catalog

Books, media, physical & digital resources